Current Opinion in Investigational Drugs is published monthly and delivers systematic and comprehensive coverage of the following therapeutic areas: Anti-infectives; Anti-inflammatory, immune-meditated and gastrointestinal; Cardiovascular, renal and metabolic; Central and peripheral nervous system; Oncological

Access to the full text or PDF of articles from Current Opinion in Investigational Drugs requires a subscription to the journal. Individual PDFs may be purchased by contacting ts.ids@thomson.com.